Hot Topics, Legal Insight and Industry Trends: Foley Hoag Newsroom Enhanced with Video Launches at BIO 2009
Boston, MA - May 19, 2009
Newsroom offers place for industry thought leaders to explore intersection of policy, business and law
The law firm Foley Hoag LLP unveils the Foley Hoag Newsroom today at BIO 2009. The enhanced Newsroom, found at foleyhoagnewsroom.com, offers timely industry insights in digital and print format from lawyers at the firm focused on the life sciences industry.
Today’s material includes a number of topics including the priorities of the new Health and Human Services Secretary, structuring an IP portfolio in a down economy, bright spots in biotechnology investing, how the in re Bilski decision will affect the biotechnology industry, biotechnology in China and the ITC, and a status on False Claims Act cases in the life sciences industry.
The Newsroom is a place where thought leaders including the media, industry executives, members of academia, venture capital and consulting firms can view timely, insightful, and occasionally provocative commentary on the intersection of law and business. Beyond the life sciences content offered for BIO 2009, the Newsroom will feature content from a variety of practice areas and industries on an ongoing basis such as business crimes and government investigations, clean technology, the environment, and high technology.
“The Foley Hoag Newsroom is a great platform for us to engage thought leaders in a variety of industries, and we’re thrilled that the life sciences practice has the opportunity to launch it at BIO 2009,” said Jeff Quillen, Partner at Foley Hoag LLP and a co-head of the Life Sciences Practice.
In addition to foleyhoagnewsroom.com, the information can be accessed by the firm’s website foleyhoag.com. Members of the media and interested parties may sign up for alerts and RSS feeds.
Foley Hoag has a longstanding relationship with the Biotechnology Industry Organization (BIO) and for the past three years has participated in its annual International Convention, one of the largest biotech gatherings in the world, via speaking panels, as an exhibitor, and as event hosts. The BIO International Convention is a forum for global thought leaders to discuss the intersection of policy, business, and law.
CATEGORIES
Venture Capital & Emerging Companies, Life Sciences, Healthcare, Business Crimes & Government Investigations, Business, Corporate Finance and Securities, Government Strategies, Intellectual Property Litigation, Intellectual Property, Medicare Coverage & Reimbursement, Mergers and Acquisitions, Patent, Product Liability & Complex Tort, Technology Transfer & Licensing